Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMC Cancer|June 1, 2005
A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosisJoerg O W Pelz, Joerg Doerfer, Werner Hohenberger, et al.
Scandinavian Journal of Gastroenterology|January 24, 2012
Surgery for colorectal peritoneal carcinomatosisTerence C Chua, Joerg O W Pelz, David L Morris
Journal of Surgical Oncology|October 22, 2008
Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosisJoerg O W Pelz, Alexander Stojadinovic, Aviram Nissan, et al.
Journal of Surgical Oncology|June 13, 2012
Summary of current therapeutic options for peritoneal metastases from colorectal cancerTerence C Chua, Jesus Esquivel, Joerg O W Pelz, et al.
BMC Cancer|June 24, 2006
Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigationsJoerg O W Pelz, J Doerfer, A Dimmler, et al.
Annals of Surgical Oncology|July 31, 2009
Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinomaTerence C Chua, Joerg O W Pelz, Alexander Kerscher, et al.
The American Surgeon|February 23, 2011
Development of a Bayesian Belief Network Model for personalized prognostic risk assessment in colon carcinomatosisAlexander Stojadinovic, Aviram Nissan, John Eberhardt, et al.
World Journal of Surgical Oncology|December 23, 2011
Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosisCarolin D Duhr, Werner Kenn, Ralph Kickuth, et al.
Annals of Surgical Oncology|January 5, 2011
Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter studyTerence C Chua, David L Morris, Akshat Saxena, et al.
BMC Cancer|December 24, 2010
Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal originJoerg O W Pelz, Terence C Chua, Jesus Esquivel, et al.
Pageof 2